NovAliX key opinion leader will be present at Discovery on Target 2023. This industry’s preeminent event on novel drug targets and technologies will be held in Boston, MA, from 25th to 28th of September 2023.
Highlighting advances in current and emerging technologies, this symposium also focuses on target validation strategies for the discovery and development of innovative therapeutic agents from biologics to small molecules.
Organized by CHI, a division of Cambridge Innovation Institute, Discovery on Target 2023 celebrates its 20th anniversary. More than 1,000 global attendees are expected.
16 conference programs will present some popular topics such as:
- protein degraders and molecular glues
- small molecules targeting RNA
- small molecules for cancer targets
- GPCR-based drug discovery
- antibodies against membrane protein targets
- and much more…
If you are also attending sessions, do not hesitate to contact our NovAlix key opinion leader at the event to set a meeting and catch up:
Dr. Frank Moffatt, Business Development Director